reglab/statecodes huggingface dataset:
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-14 - Security and Anti-Counterfeiting

Current through July 13, 2024
(a) All facilities used for drug distribution
				shall be secure from unauthorized entry as follows:
(i) Access from outside the premises shall be
				kept to a minimum and be well controlled;
(ii) The outside perimeter of the premises
				shall be well lighted;
(iii) Entry
				into areas where prescription drugs are held shall be limited to authorized
				personnel;
(iv) All facilities
				shall be equipped with an alarm system to detect unauthorized entry after
				hours; and
(v) All facilities shall
				be equipped with a security system that will provide suitable protection
				against theft and diversion. When appropriate, the security system shall
				provide protection against theft or diversion that is facilitated or hidden by
				tampering with computers or electronic records.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-15 - Examination of Materials

Current through July 13, 2024
(a) Upon receipt, each shipping container
				shall be visually examined for identity and to determine if it may contain
				suspect products. This examination shall be adequate to reveal container damage
				that would suggest possible suspect product or other damage to the
				contents.
(b) The prescription
				drugs found to be unacceptable under paragraph "a" above shall be quarantined
				from the rest of the stock.
(c)
				Each outgoing shipment shall be carefully inspected for identity of the
				prescription drug products and to ensure that there is no delivery of
				prescription drugs that have been damaged in storage or held under improper
				conditions.
(d) All entities shall
				comply with reporting requirements and exchange transaction history,
				transaction information, and transaction statements as outlined in federal
				law.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 8 - WHOLESALE DISTRIBUTOR REGULATIONS › Section 8-16 - Policies and Procedures

Current through July 13, 2024
All entities shall establish, maintain and adhere to written
				  policies and procedures, which shall be followed for the receipt, security,
				  storage, inventory, transport, shipping and wholesale distribution of
				  prescription drugs, including policies and procedures for identifying,
				  recording and reporting losses or thefts, and for correcting all errors and
				  inaccuracies in inventories. Policies and procedures shall include the
				  following:
(a) A procedure to be
				followed for handling recalls and withdrawals of prescription drugs due to:
(i) Any action initiated at the request of
				the FDA or any other federal, state or local law enforcement or other
				governmental agency, including the board of pharmacy; or
(ii) Any volunteer action by the manufacturer
				to remove defective or potentially defective prescription drugs from the
				market.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 9 - PATIENT COUNSELING AND PROSPECTIVE DRUG USE REVIEW REGULATIONS › Section 9-2 - Definitions

Current through July 13, 2024
(a) "Reasonable effort" means that degree of
				effort which a pharmacist of ordinary prudence and accepted professional duty
				would exercise in similar circumstances.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 9 - PATIENT COUNSELING AND PROSPECTIVE DRUG USE REVIEW REGULATIONS › Section 9-3 - Patient Profile Records

Current through July 13, 2024
(a) A profile
				record shall be maintained by all pharmacies for patients for whom
				prescriptions are dispensed. The profile record shall provide for the immediate
				retrieval of information of previously dispensed drugs and devices. The
				pharmacist shall be responsible for maintaining the following patient
				information for each new prescription:
(i)
				Full name of the patient for whom the drug is intended;
(ii) Address and telephone number of the
				patient;
(iii) Patient's age or
				date of birth and gender;
(iv) A
				list of all prescription drug orders obtained at the pharmacy during the two
				years immediately preceding the most recent entry showing the name of the drug
				or device, prescription number, strength of the drug, the quantity, date
				received and the name of the prescriber;
(v) Pharmacist comments relevant to the
				individual's drug therapy, including any information peculiar to the specific
				patient or drug.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 9 - PATIENT COUNSELING AND PROSPECTIVE DRUG USE REVIEW REGULATIONS › Section 9-4 - Prospective Drug Use Review

Current through July 13, 2024
(a) A pharmacist
				shall review the patient record and each prescription drug order presented for
				dispensing by identifying:
(i)
				Overutilization or underutilization;
(ii) Therapeutic duplication;
(iii) Drug-disease
				contraindications;
(iv) Drug-drug
				contraindications;
(v) Incorrect
				drug dosage or duration of drug treatment;
(vi) Drug-allergy interactions; and
(vii) Clinical abuse/misuse.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 9 - PATIENT COUNSELING AND PROSPECTIVE DRUG USE REVIEW REGULATIONS › Section 9-5 - Patient Counseling

Current through July 13, 2024
(a) Upon receipt of
				a prescription and following a review of the patient's record, a pharmacist or
				a pharmacy intern shall personally offer to discuss matters which will enhance
				or optimize drug therapy with each patient or caregiver of the patient.
				Non-resident pharmacies/pharmacists are not exempt from this regulation Such
				elements may include the following:
(i) Name
				and description of the drug;
(ii)
				Dosage form, dose, route of administration, and duration of drug
				therapy;
(iii) Intended use of the
				drug and expected action;
(iv)
				Special directions and precautions for preparation, administration, and use by
				the patient;
(v) Common severe side
				or adverse effects or interactions and therapeutic contraindications that may
				be encountered, including their avoidance, and the actions required if they
				occur;
(vi) Techniques for
				self-monitoring drug therapy;
(vii)
				Proper storage;
(viii) Prescription
				refill information;
(ix) Action to
				be taken in the event of a missed dose; and
(x) Comments relevant to the individual's
				drug therapy, including any other information peculiar to the specific patient
				or drug or refusal of counseling.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 9 - PATIENT COUNSELING AND PROSPECTIVE DRUG USE REVIEW REGULATIONS › Section 9-6 - Retrospective Drug Use Review

Current through July 13, 2024
(a) "Retrospective
				drug use review" means the monitoring for:
(i) Therapeutic appropriateness;
(ii) Over-utilization and
				under-utilization;
(iii)
				Appropriate use of generic products;
(iv) Therapeutic duplication;
(v) Drug-disease contraindications;
(vi) Drug-drug interactions;
(vii) Incorrect dosage;
(viii) Duration of drug treatment;
				and
(ix) Clinical abuse/misuse
				after the drug has been dispensed.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-2 - Definitions

Current through July 13, 2024
"Pharmacy Technician-in-Training" means an individual who is
				  registered with the Board to receive on-the-job training in preparation for
				  licensure as a pharmacy technician.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-3 - Qualifications for Pharmacy Technicians and Pharmacy Technician-in-Training

Current through July 13, 2024
(a) Be at least 18 years of age;
(b) Complete a background check through the
				Wyoming division of Criminal Investigation (DCI);
(c) Have no history of drug abuse or provide
				satisfactory evidence of rehabilitation;
(d) Hold a high school diploma or its
				equivalent; and
(e) Have complete
				requirements for registration.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-4 - Requirements for Pharmacy Technicians and Pharmacy Technicians-in-Training

Current through July 13, 2024
(a) Wear a name badge with the appropriate
				designation "Pharmacy Technician" or "Pharmacy Technician-in-Training" at all
				times when in or near the pharmacy area; and
(b) Identify themselves as the appropriate
				level of technician in all telephone conversations while on duty.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-5 - Pharmacy Technician-in-Training Registration

Current through July 13, 2024
(a) A
				pharmacy technician-in-training shall apply to the Board for a training permit
				on an application supplied by the Board and shall pay the fee required before
				starting on-the-job training.
(i) This permit
				shall be valid for two years from the date of original issuance;
(ii) This permit shall include the sponsoring
				pharmacy; and
(iii) If the
				sponsoring pharmacy changes, the technician-in-training shall immediately
				submit a pharmacy sponsor transfer form.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-6 - Pharmacy Functions for Technicians-in-Training

Current through July 13, 2024
(a) A
				pharmacy technician-in-training may perform the following functions under the
				direct supervision of a licensed pharmacist:
(i) Retrieve the product from stock, count,
				pour, reconstitute, place product in a prescription container, and affix the
				label;
(ii) Make computer entries
				for new or refill prescriptions;
(iii) Contact the practitioner's office and
				obtain refill authorizations for any prescription provided there are no
				changes; and
(iv) Restock drugs for
				those sites where the pharmacy has an emergency drug permit.
(v) Stock automated drug dispensing units,
				floor stock, crash carts, after-hour drug cabinets, sterile solutions and unit
				dose cart preparation;
(vi)
				Repackage unit dose and/or unit of issue packaging;
(vii) Conduct inspections; and
(viii) Input practitioner medication
				orders.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-7 - Pharmacy Technician Registration; Fees; Licenses

Current through July 13, 2024
(a)
				Individuals shall apply for pharmacy technician licensure by completing an
				application, providing evidence of current certification by the Pharmacy
				Technician Certification Board (PTCB) or National Healthcareer Association
				(ExCPT) and paying the required fee. The Board reserves the right to require an
				interview of the applicant prior to a pharmacy technician license being
				issued;
(b) A pharmacy technician
				must apply to renew their license each year on or before December 31 and submit
				payment of the required renewal fee. The Board shall assess a late payment fee
				for any renewal application postmarked or filed after December 31;
(c) If the pharmacy technician fails to renew
				before December 31, the license expires ten (10) days after a written notice to
				renew is sent to the holder by certified mail, to the address last recorded for
				the licensee;
(d) An expired
				license may be restored by the Board upon compliance with this section no later
				than March 31 following expiration of the license;
(e) A pharmacy technician may petition the
				Board for reinstatement of an expired license. To be considered for
				reinstatement, the pharmacy technician must submit the following:
(i) A letter requesting
				reinstatement;
(ii) Payment of
				annual fees, including late payment fees, for those years which the license was
				expired up to a maximum of five (5) years;
(iii) Evidence of current certification by
				the PTCB or ExCPT; and
(iv) Proof
				of continuing pharmacy education for those years the license was expired, up to
				a maximum of five (5) years.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-8 - Reinstatement of a Revoked or Suspended Pharmacy Technician License

Current through July 13, 2024
(a) A pharmacy technician whose license has
				been revoked or suspended by the Board may file an application, on a form
				supplied by the Board, requesting a hearing to present evidence to show why the
				license should be reinstated subject to the following:
(i) A pharmacy technician whose license was
				revoked by the Board may not file an application requesting a hearing until
				thirty-six (36) months have elapsed from the date the order revoking the
				pharmacy technician license became final;
(ii) A pharmacy technician whose license was
				suspended by the Board may not file an application requesting a hearing until
				one-half (1/2) of the suspension so ordered by the Board has elapsed;
(iii) A pharmacy technician shall submit an
				application fee of one hundred twenty five dollars ($125.00) and pay for the
				cost of the hearing, if the Board issues an order denying reinstatement. The
				application fee is nonrefundable;
(iv) The applicant must complete all
				questions and provide all information requested on the application;
(v) An incomplete application and the
				accompanying fee will be returned and a hearing date will not be set by the
				Board; and
(vi) In In the
				application, the pharmacy technician shall authorize any health professional
				who has examined or treated the applicant to disclose a diagnosis and the
				reasons for it to the Board and the Board staff.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-9 - Pharmacy Functions for Pharmacy Technicians

Current through July 13, 2024
(a) A
				pharmacy technician may perform the pharmacy functions previously mentioned in
				this chapter for technicians-in-training, as well as the following:
(i) Compounding - Compounded prescription
				orders shall be reviewed by a pharmacist. The PIC shall certify competency of
				the pharmacy technician prior to allowing a pharmacy technician to assist the
				pharmacist in compounding, and annually thereafter. Documentation of the
				competency shall remain on file at the pharmacy and be available for inspection
				by the Board for each pharmacy technician, and shall include, but not be
				limited to, documentation of the following skills:
(A) Knowledge and understanding of FDA's Good
				Manufacturing Practices;
(B)
				Weights and measures;
(C)
				Calculations;
(D) Use of torsion
				balance or electronic scales'
(E)
				Knowledge of various techniques utilized to compound products;
(F) Labeling requirements;
(G) Aseptic technique;
(H) Use and maintenance of laminar and/or
				vertical flow air hood;
(I)
				Knowledge in handling chemotherapeutic agents;
(J) Dating requirements; and
(K) Record keeping requirements.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-10 - Pharmacy Functions Not Permitted for all Technicians

Current through July 13, 2024
(a)
				No pharmacy technician or technician-in-training shall:
(i) Receive a new prescription order verbally
				from a prescriber or other person authorized by law;
(ii) Perform evaluations and interpretations
				of a prescription;
(iii) Obtain any
				needed clinical clarifications prior to filling;
(iv) Review and analyze any clinical data in
				a patient's medication record or chart;
(v) Perform professional consultation with
				any prescriber, nurse, other health care professional or any
				patient/customer;
(vi) Offer to
				counsel; and
(vii)
				Counsel.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-11 - Functions When a Pharmacist is Absent

Current through July 13, 2024
(a) When no
				pharmacist is in the pharmacy, but at least one supervising pharmacist remains
				in the building, the pharmacy technician or pharmacy technician-in-training may
				perform functions as outlined in this Chapter, provided no prescription product
				leaves the pharmacy until the pharmacist returns and authorizes the
				release;
(b) When no supervising
				pharmacist is in the building, a retail pharmacy may not remain open, and staff
				may not remain in the pharmacy; and
(c) An institutional pharmacy may not remain
				open. A pharmacy technician or pharmacy technician-in-training may remain in
				the pharmacy, but may not perform pharmacy functions. If a drug needs to be
				removed from the pharmacy, those procedures as outlined in Chapter 12 shall be
				followed.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 10 - PHARMACY TECHNICIAN REGULATIONS › Section 10-12 - Legal and Professional Responsibilities

Current through July 13, 2024
A pharmacy technician or pharmacy technician-in-training
				  shall not violate the Wyoming Pharmacy Act or the Wyoming Controlled Substances
				  Act or their rules or regulations.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-2 - Purpose

Current through July 13, 2024
The purpose of this chapter is to provide standards for the
				  conduct, practice activities, and operation of a pharmacy located in a hospital
				  or other inpatient facility that is licensed under the Wyoming Department of
				  Health. The intent of these standards is to establish a minimum acceptable
				  level of pharmaceutical care to the patient so that the patient's health is
				  protected while contributing to positive patient outcomes.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-3 - Scope of Chapter

Current through July 13, 2024
This chapter applies to any person, partnership, corporation,
				  limited liability company, or other entity engaging in the practice of pharmacy
				  in an institutional facility, as defined below, within this
				  state.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-4 - Definitions

Current through July 13, 2024
(a) "Automated Dispensing Device" means a
				mechanical system that performs operations or activities, other than
				compounding or administration, relative to the storage, packaging, dispensing,
				or distribution of medications, and which collects, controls and maintains all
				transaction information.
(b)
				"Beyond-Use Date" means a date placed on a prescription label at the time of
				dispensing that is intended to indicate to the patient or caregiver a time
				beyond which the contents of the prescription are not recommended to be
				used.
(c) "Clean Room" means a room
				with a minimum of an ISO Class 7 environment as defined in chapter
				17:
(d) "Drug Room" means a secure
				and lockable location within an inpatient care facility that does not have an
				institutional pharmacy.
(e)
				"Emergency Drug Cart (crash cart)" means a cart containing those drugs that may
				be required to meet the immediate therapeutic needs of patients
(f) "Floor Stock" means prescription drugs
				not labeled for a specific patient and maintained at a nursing station or other
				institutional facility department (excluding the institutional pharmacy) for
				the purpose of administration to a patient of the institutional
				facility.
(g) "Formulary" means a
				continually revised compilation of pharmaceuticals that reflects the current
				clinical judgment of the pharmacy staff and medical staff of the institutional
				facility.
(h) "Institutional
				Facility" means a hospital, convalescent home, nursing home, extended care
				facility, correctional or penal facility, or any other organization, public or
				private, which provides a physical environment for patients to obtain medical,
				surgical, and/or nursing services, except those places where physicians,
				dentists, veterinarians, or other practitioners of the healing arts engage in
				private office practice.
(i)
				"Institutional Pharmacy" means a pharmacy where medications are dispensed to
				other health care professionals for administration to institutionalized
				patients served by an institutional facility, and which is:
(i) Located within the institutional
				facility, or
(ii) Located outside
				the institutional facility but only provides pharmacy services to
				institutionalized patients.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-5 - Licensing

Current through July 13, 2024
(a) All institutional pharmacies shall
				register annually with the Board on a form provided by the Board. Institutional
				pharmacies that also provide outpatient pharmacy services shall also register
				as a retail pharmacy.
(b) All
				institutional pharmacy licenses shall expire on June 30. Renewal notices will
				be sent by the Board's office at least sixty days prior to June 30.
(c) The fee established in chapter 2, will be
				charged for issuance of a new license and renewal. The late fee established in
				chapter 2, will be charged, in addition to the renewal fee, for any license
				renewal application that is postmarked after June 30 or is hand-delivered to
				the Board office after June 30.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-6 - Change of Ownership

Current through July 13, 2024
(a) If an
				institutional pharmacy changes ownership, it must obtain a new and separate
				registration from the Board. In the case of a corporation, limited liability
				company, or partnership holding an institutional pharmacy license, the Board
				shall be notified and a new license applied for any time the majority of stock
				in the corporation is sold or a majority of the partners of the partnership or
				members of the limited liability company change.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-7 - Personnel

Current through July 13, 2024
(a) A Pharmacist-in-Charge (PIC), who is
				licensed to engage in the practice of pharmacy in Wyoming, shall direct each
				institutional pharmacy.
(b) The
				storage, compounding, repackaging, dispensing, and distribution of drugs by an
				institutional pharmacy shall be under the direction, supervision, and
				responsibility of the PIC. Depending upon the size and needs of the
				institutional facility, pharmacy service may be provided on a full or part-time
				basis.
(i) In hospital institutional
				facilities with fifty (50) or more acute care beds, a pharmacist shall be in
				the hospital institutional facility during the time the institutional pharmacy
				is open for pharmacy services, except in case of emergencies. Pharmacy services
				shall be provided for a minimum of forty (40) hours per week, unless an
				exception is made upon written request by the institutional facility and with
				express permission of the Board.
(ii) In hospital institutional facilities
				with less than fifty (50) acute care beds, a pharmacist shall be in the
				hospital institutional facility during the time the institutional pharmacy is
				open for pharmacy services. Upon written request by the hospital institutional
				facility, and with the express permission of the Board, the services of a
				pharmacist may be on a part-time basis, according to the needs of the hospital
				institutional facility. The services of a pharmacist shall be required as
				follows:
(A) In hospital institutional
				facilities with one to twenty-five (1-25) acute care beds, a pharmacist shall
				be on-site a minimum of five (5) hours per week.
(B) In hospital institutional facilities with
				twenty-six to forty-nine (26-49) acute care beds, a pharmacist shall be on-site
				a minimum of twenty (20) hours per week.
(iii) In a non-hospital institutional
				facility, a pharmacist shall be available commensurate with the needs of the
				institutional facility. The hours shall be identified on the initial
				application and provided with each license renewal.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-8 - Environment

Current through July 13, 2024
(a) The institutional pharmacy shall be
				enclosed and lockable.
(b) The
				institutional pharmacy shall have adequate space necessary for the storage,
				compounding, labeling, dispensing, and sterile preparation of drugs prepared in
				the institutional pharmacy, depending on the size and scope of pharmaceutical
				services provided.
(c) A sink with
				hot and cold running water, exclusive of restroom facilities, shall be in the
				institutional pharmacy.
(d) The
				institutional pharmacy shall be arranged in an orderly fashion and shall be
				kept clean. All required equipment shall be clean and in good operating
				condition.
(e) The institutional
				pharmacy shall be properly lighted and ventilated.
(f) The temperature of the institutional
				pharmacy shall be maintained within a range of 59 to 86 degrees Fahrenheit (15
				to 30 degrees Centigrade). The temperature of the refrigerator shall be
				maintained within a range of 36 to 46 degrees Fahrenheit (2 to 8 degrees
				Centigrade) and the freezer shall be maintained within a range of -13 to +14
				degrees Fahrenheit (-25 to -10 degrees Centigrade).
(g) The institutional pharmacy shall store
				drugs for external use, separately from internal and injectable
				medications.
(h) If the
				institutional pharmacy compounds sterile pharmaceuticals, they shall be
				prepared in accordance with chapter 17.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-9 - References

Current through July 13, 2024
Each institutional pharmacy shall maintain in its library at
				  least one current reference (text or electronic format, including online access
				  or PDA) from each category listed below.
(a) Drug monograph reference:
(b) Stability and incompatibility
				reference:
(c) Reference on drug
				availability and identification:
(d) Drug interactions:
(e) Reference on pharmacology and
				therapeutics:
(f) Current copies of
				the Wyoming Pharmacy Act and Rules and Regulations, and Wyoming Controlled
				Substances Act and Rules and Regulations, text or electronic format, and
				including internet access to the Board website.
(g) Wyoming State Board of Pharmacy quarterly
				newsletter from the Board website.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-10 - Equipment

Current through July 13, 2024
(a) Institutional pharmacies distributing
				medication orders shall have the following equipment:
(i) Refrigerator, including a system or
				device to monitor the temperature daily to ensure that proper storage
				requirements are met;
(ii) Computer
				and software appropriate for the institutional facility.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-11 - Security

Current through July 13, 2024
(a) No one shall be permitted in the
				institutional pharmacy unless the pharmacist is on duty, except as provided in
				this chapter. If the pharmacist must leave the institutional pharmacy for an
				emergency or patient care duties, pharmacy technicians may remain to perform
				duties as authorized by the PIC, provided that the pharmacist remains in the
				institutional facility.
(b) All
				institutional pharmacy areas shall be capable of being locked. The PIC shall
				designate in writing, by title and specific area, those persons who shall have
				access to specific institutional pharmacy areas.
(c) Each pharmacist on duty shall be
				responsible for the security of the institutional pharmacy.
(d) Pharmacists, technicians, clerical staff,
				and interns working in the institutional pharmacy shall wear identification
				badges, including name and position, whenever on duty.
(e) The PIC shall be responsible for policies
				and procedures for the safe distribution and control of prescription blanks and
				tamper resistant paper.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-12 - Absence of Pharmacist

Current through July 13, 2024
(a) General. During
				such times as institutional pharmacy services are not available on-site,
				arrangements shall be made in advance by the PIC for provision of drugs by use
				of floor stock, ADD, and/or access to the institutional pharmacy.
(b) If floor stock is used, the following
				shall prevail:
(i) In the absence of a
				registered pharmacist, medication for inpatients shall be obtained from a
				locked cabinet or other enclosure located outside the institutional pharmacy to
				which only authorized nurses may have access.
(ii) The PIC shall develop inventory listings
				of those drugs to be included in such floor stock, and shall ensure that:
(A) Such drugs are available, properly
				labeled;
(B) Such drugs are
				prepackaged in appropriately small amounts, unless commercially prepared
				packages, (e.g. ophthalmics, otics, topicals, etc.)
(C) All drugs shall be checked and
				replenished as needed;
(D) A record
				shall be maintained, and shall include:
(I)
				The date and time of removal of a drug;
(II) The patient's name and
				location;
(III) The name, strength,
				dosage form, and quantity of drug removed; and
(IV) The printed name and signature of the
				nurse removing the drug.
(E) Written policies and procedures are
				established.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-13 - Emergency Outpatient Medication

Current through July 13, 2024
(a) Institutional
				facilities which provide for the administration and distribution of emergency
				pharmaceuticals to outpatients and/or inpatients being discharged during hours
				when normal community or outpatient Institutional pharmacy services are not
				available, may:
(i) Allow a designated nurse
				on the original written or electronic order of a practitioner to administer and
				distribute medications pursuant to the following requirements:
(A) A written or electronic order of a
				practitioner authorized to prescribe a drug is presented.
(B) The medication is prepackaged by a
				pharmacist or a technician under a pharmacist's supervision or is administered
				and distributed utilizing an automated drug dispensing device;
(C) The quantity of medication administered
				and distributed is limited to a seventy-two hour (72-hour) supply. Exceptions
				to the 72-hour supply include: oral pediatric antibiotic preparations, otics,
				ophthalmics, topicals, inhalers, nitroglycerin tablets, nasal sprays,
				manufacture packaged courses of therapy such as Z-paks or dosepaks;
				and
(D) The labeling of the
				administered and distributed medication includes:
(I) Name, address, and telephone number of
				the institutional facility;
(II)
				Name of patient;
(III) Name of
				drug, strength, and quantity;
(IV)
				Directions for use;
(V)
				Date;
(VI) Accessory cautionary
				information, as required for patient safety;
(VII) Name of practitioner; and
(VIII) Initials of the nurse administering
				and distributing the medication.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-14 - Emergency Drug Carts (crash carts)

Current through July 13, 2024
Emergency drug carts may be used by institutional facilities
				  if:
(a) All drug kits are supplied, and
				kept up-to-date, under the supervision of a licensed pharmacist;
(b) A committee composed of the PIC, nursing
				staff, and medical staff of the institutional facility develops a standard drug
				inventory, including kind and quantity of each drug;
(c) All drug kits are equipped with a
				breakable seal, and are secure from access by unauthorized persons;
(d) A listing of all drugs, their respective
				strength, quantity, and location, shall be placed on the cart in a conspicuous
				location. If the pharmacy which services this emergency drug cart is not
				located within the institutional facility, the name, address, and telephone
				number of the pharmacy shall be displayed in a conspicuous location;
(e) All drugs are properly labeled;
(f) The drugs are distributed, pursuant to a
				valid order, by authorized personnel, and the pharmacist is notified of entry
				into the emergency drug cart; and
(g) The PIC, nursing staff, and medical staff
				develop and implement written policies and procedures for using emergency drug
				carts.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-15 - Automated Dispensing Devices

Current through July 13, 2024
(a) No drug shall
				be distributed or issued by the use of any automated dispensing device unless
				the device and method of operation ensure the purity, potency, and integrity of
				the drug, protect the drug from diversion, and provided that:
(i) The device shall be stocked with drugs
				only by or under the supervision of a pharmacist;
(ii) The device shall be used only for the
				furnishing of drugs for administration to patients of that institutional
				facility; and
(iii) At the time of
				removal of any drug from the device, it shall automatically make a written or
				electronic record to be retained by the pharmacist for at least one (1) year,
				indicating:
(A) The date of removal of the
				drug;
(B) The name, strength,
				dosage form, and quantity of drug removed;
(C) The name of the patient for whom the drug
				was ordered; and
(D) The name or
				identification code of the nurse removing the drug from the device.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-16 - Parenteral Medications

Current through July 13, 2024
(a) The PIC shall
				be responsible for the preparation, sterilization, labeling, and dispensing of
				parenteral medications prepared within the institutional facility and shall
				participate in the education and training, including the provision of
				appropriate incompatibility information, of all personnel involved in the
				preparation of parenteral medications.
(b) If intravenous admixtures are prepared
				within the institutional facility, the institutional pharmacy shall have
				adequate equipment, personnel, and space for such preparation. The compounding
				and labeling of intravenous admixtures, including all total parenteral
				nutrition, shall be performed by, or under, the direct supervision of a
				pharmacist; however, if twenty-four hour (24-hour) pharmacy service is not
				provided at the institutional facility, the PIC shall establish written
				policies and procedures to be followed in the preparation of intravenous
				admixtures when the institutional pharmacy is closed or in emergency
				situations.
(c) All admixtures
				shall be labeled with a distinctive supplementary label, indicating the name
				and amount of drug added, date and time of addition, beyond use date, and rate
				of administration, and the name or identification code of the person adding the
				drug.
(d) The PIC shall be
				responsible for removing concentrated electrolytes (including, but not limited
				to: potassium chloride, potassium phosphate, sodium chloride greater than 0.9%)
				from patient care areas and limiting their access to pharmacists. If
				twenty-four hour (24-hour) on-call status for pharmacists is not available, the
				institutional facility must utilize the most trained professional available to
				process concentrated electrolytes. Training in the safe use of concentrated
				electrolytes should be conducted by the institutional pharmacy for
				non-pharmacist staff with access to concentrated electrolytes. Evidence of
				training will be documented and retrievable, and the institutional facility
				will have policies and procedures that detail this process. Premixed large
				volume intravenous solutions containing electrolytes and premixed potassium
				bolus doses will be used whenever possible.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-17 - Practitioner's Orders

Current through July 13, 2024
(a) All orders for
				drugs shall be transmitted to the institutional pharmacy by electronic order
				entry, or by means of an order format that is capable of producing a direct
				copy or an electronically reproduced facsimile. A pharmacist shall review the
				practitioner's order before the initial dose of medication is dispensed
				provided that, in emergencies or when pharmacy services are not available, the
				medication order shall be reviewed by the pharmacist as soon as possible.
				Verification of the accuracy of the medication dispensed and of any
				transcriptions made of that order shall be documented by the initials of the
				pharmacist so certifying.
(b)
				Orders for drugs for use by inpatients shall, at a minimum, contain the patient
				name and location, drug name, strength, directions for use, date, and
				practitioner's written or electronic signature or written or electronic
				signature of the practitioner's agent.
(c) Orders for outpatient dispensing shall
				meet the requirements of chapter 2.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-18 - Dispensing

Current through July 13, 2024
(a) If unit-dose packaging is used,
				medication for each patient, when not supplied by an automated dispensing
				device, shall be distributed and stored in separate trays, drawers,
				compartments, or containers assigned to that patient and bearing the patient's
				name and location.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-19 - Investigational Drugs and Protocols

Current through July 13, 2024
(a) All
				investigational drugs shall be stored in the institutional pharmacy and
				distributed only from the institutional pharmacy. Basic information concerning
				the dosage form, route of administration, strength, actions, uses, side
				effects, adverse effects, interactions, and symptoms of toxicity of such drugs
				shall be available in the institutional pharmacy. investigational drugs shall
				be properly labeled and shall be administered only under the personal and
				direct supervision of the principal physician-investigator or his or her
				authorized clinician(s) with prior approval of the appropriate committee(s) of
				the institutional facility and with verifications that the patient (or his or
				her legal designee) has signed the informed consent form.
(b) A copy of all investigational drug
				protocols shall be on file in the institutional pharmacy.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-20 - Inspections

Current through July 13, 2024
The PIC or his/her designee shall document on at least a
				  quarterly basis an inspection of all drug storage areas in the institutional
				  facility. Records of such inspections shall be dated, signed, and maintained so
				  as to be readily retrievable at the institutional pharmacy for at least two (2)
				  years. These inspections must ascertain that:
(a) Test reagents, germicides, and
				disinfectants are stored separately from medications;
(b) External medications are stored
				separately from internal medications;
(c) Drugs are stored at the proper
				temperature;
(d) There are no
				outdated or deteriorated drugs;
(e)
				All drugs are properly labeled;
(f)
				Emergency drug carts (crash carts) are adequate and in proper supply;
(g) Medication storage areas are locked when
				not in use, and only authorized individuals have access to these
				areas;
(h) Distribution and
				administration of controlled substances are properly and adequately
				documented;
(i) Telephone numbers
				of the regional poison control center and other emergency assistance
				organizations are posted;
(j)
				Metric-apothecaries' weight and measure conversion tables and charts are
				available; and
(k) Adequate
				pharmaceutical references are available at these areas.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-21 - Medications brought into the institution by patients

Current through July 13, 2024
Whenever patients bring drugs into an institutional facility,
				  such drugs shall not be administered unless they can be precisely identified;
				  administration shall be pursuant to a practitioner's order. If such drugs are
				  not to be administered, they shall be delivered to the institutional pharmacy,
				  packaged, sealed, and returned to an adult (18 years or older) member of the
				  patient's immediate family (spouse, unless legally separated; adult child;
				  parent; grandparent; adult brother or sister; adult grandchild), the patient's
				  legal guardian or conservator, or the patient's designated agent, or they shall
				  be stored and returned to the patient upon discharge, only after advice is
				  provided regarding continuing the returned medication.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 12 - INSTITUTIONAL PHARMACY PRACTICE REGULATIONS › Section 12-22 - Controlled Drugs

Current through July 13, 2024
(a) All controlled
				substances issued by the institutional pharmacy to any institutional facility
				department, excluding those controlled substances for which the dispensing and
				record-keeping are maintained utilizing an automated drug dispensing device,
				shall be labeled and accompanied with control sheets (proof of use forms) that
				provide space for recording:
(i) The drug
				name, strength, and dosage form;
(ii) The date and time of
				administration;
(iii) The quantity
				administered;
(iv) Name of
				patient;
(v) The signature of the
				nurse who administered the medication, when issued to nursing units;
				and
(vi) The signature of the
				practitioner who administered the medication and a witness, when issued to
				surgery or other specialized areas such as endoscopy labs.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 13 - NON-STERILE COMPOUNDING › Section 13-2 - Definitions

Current through July 13, 2024
(a) "Active Ingredient" means an ingredient
				added to a compounded prescription product that provides the therapeutic effect
				desired from the compounded prescription product. This does not include "inert"
				ingredients.
(b) "Beyond-use Date
				(BUD)" means a date after which a compounded product should not be
				used.
(c) "Component" means any
				ingredient used in the compounding of a drug product, including those
				ingredients that may not appear in the labeling of such product.
(d) "Compounding" means and includes the
				preparation, mixing, or assembling of a drug or device, and the packaging and
				labeling incident thereto for sale or dispensing:
(i) as the result of a practitioner's
				prescription drug order or initiative based on the
				practitioner/patient/pharmacist relationship in the course of his/her
				professional practice.
(ii) for the
				purpose of research, teaching, or chemical analysis, or
(iii) in anticipation of prescription drug
				orders based on routine, regularly observed prescribing patterns.
However, "compounding" does not include mixing or
				  reconstituting of non-sterile products performed in accordance with directions
				  contained in approved labeling provided by the product's manufacturer and other
				  manufacturer directions consistent with that labeling.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0001 - Pharmacy, Board of › Chapter 13 - NON-STERILE COMPOUNDING › Section 13-3 - General Provisions

Current through July 13, 2024
(a) Based on the
				existence of a pharmacist/patient/practitioner relationship and the
				presentation of a valid prescription, or in anticipation of prescription
				medication orders based on routine, regularly observed prescribing patterns,
				pharmacists may compound, for an individual patient, medications or dosage
				forms that are not commercially available in the marketplace.
(b) Pharmacists shall, when procuring active
				ingredients for compounding, obtain a Certificate of Analysis (COA) for each
				lot number procured, and shall retain each COA for a period of not less than
				two (2) years from the date the container is emptied. COAs shall be available
				for review by Board inspectors. Each COA. must be issued by a firm located in
				the United States. If one is not available from the vendor, the pharmacist
				shall procure one from a laboratory located in the United States. COAs are not
				required if the active ingredient utilized is designated USP or NF.
(i) If the product is not designated as USP
				or NF, then the following minimum information is required on the COA:
(A) Product name;
(B) Lot number;
(C) Expiration date; and
(D) Assay.